【国内首款FDA-GRAS认证巴西甜蛋白实现量产】金斯瑞生物科技股份有限公司今日对外宣布，旗下子公司百斯杰生物位于中国济南的甜蛋白自动化智能产线竣工。这标志着全球首条专为甜蛋白设计的商业化生产线正式落成，也表明百斯杰在原有甜蛋白产品工业化生产能力的基础上完成战略跃升，率先实现了全产业链贯通，成为全球合成生物甜蛋白领域唯一拥有自主专线量产能力的行业领跑者。该条自动化产线的竣工，使国内首款获得美国食品药品监督管理局GRAS认证的Brazzein巴西甜蛋白正式迈入工业级规模化量产新阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.